Vsevolod E. Kostrubsky

1.3k total citations
20 papers, 1.1k citations indexed

About

Vsevolod E. Kostrubsky is a scholar working on Pharmacology, Oncology and Hepatology. According to data from OpenAlex, Vsevolod E. Kostrubsky has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 12 papers in Oncology and 5 papers in Hepatology. Recurrent topics in Vsevolod E. Kostrubsky's work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (10 papers) and Drug-Induced Hepatotoxicity and Protection (9 papers). Vsevolod E. Kostrubsky is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (10 papers) and Drug-Induced Hepatotoxicity and Protection (9 papers). Vsevolod E. Kostrubsky collaborates with scholars based in United States, United Kingdom and Germany. Vsevolod E. Kostrubsky's co-authors include Jacqueline F. Sinclair, Steven Wrighton, Stephen C. Strom, Sheryl G. Wood, Peter R. Sinclair, George K. Michalopoulos, Juliana G. Szakacs, Raman Venkataramanan, William J. Bement and Kenneth Dorko and has published in prestigious journals such as Hepatology, Biochemical and Biophysical Research Communications and Journal of Hepatology.

In The Last Decade

Vsevolod E. Kostrubsky

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vsevolod E. Kostrubsky United States	19	619	479	263	213	172	20	1.1k
Damrong Ratanasavanh France	21	806 1.3×	498 1.0×	208 0.8×	418 2.0×	118 0.7×	46	1.6k
Summer Jolley United States	10	434 0.7×	272 0.6×	146 0.6×	167 0.8×	125 0.7×	11	825
Robert Elsby United Kingdom	20	551 0.9×	729 1.5×	94 0.4×	367 1.7×	224 1.3×	25	1.6k
Toru Horie Japan	16	581 0.9×	893 1.9×	124 0.5×	285 1.3×	249 1.4×	30	1.4k
Sheryl G. Wood United States	22	614 1.0×	320 0.7×	119 0.5×	265 1.2×	51 0.3×	28	1.1k
Andreas Benesic Germany	17	449 0.7×	141 0.3×	287 1.1×	243 1.1×	152 0.9×	30	1.1k
Douglas M. Heuman United States	10	418 0.7×	503 1.1×	179 0.7×	226 1.1×	312 1.8×	15	1.0k
Michael Török Switzerland	16	291 0.5×	418 0.9×	71 0.3×	483 2.3×	231 1.3×	24	1.3k
Kajsa P. Kanebratt Sweden	13	556 0.9×	307 0.6×	271 1.0×	412 1.9×	224 1.3×	19	1.4k
Jonathan P. Jackson United States	15	302 0.5×	279 0.6×	144 0.5×	233 1.1×	88 0.5×	21	821

Countries citing papers authored by Vsevolod E. Kostrubsky

Since Specialization

Citations

This map shows the geographic impact of Vsevolod E. Kostrubsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vsevolod E. Kostrubsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vsevolod E. Kostrubsky more than expected).

Fields of papers citing papers by Vsevolod E. Kostrubsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vsevolod E. Kostrubsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vsevolod E. Kostrubsky. The network helps show where Vsevolod E. Kostrubsky may publish in the future.

Co-authorship network of co-authors of Vsevolod E. Kostrubsky

This figure shows the co-authorship network connecting the top 25 collaborators of Vsevolod E. Kostrubsky. A scholar is included among the top collaborators of Vsevolod E. Kostrubsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vsevolod E. Kostrubsky. Vsevolod E. Kostrubsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koschier, Francis J., et al.. (2011). In vitro effects of ethanol and mouthrinse on permeability in an oral buccal mucosal tissue construct. Food and Chemical Toxicology. 49(10). 2524–2529. 26 indexed citations

Feng, Bo, Jinghai J. Xu, Yi‐An Bi, et al.. (2009). Role of Hepatic Transporters in the Disposition and Hepatotoxicity of a HER2 Tyrosine Kinase Inhibitor CP-724,714. Toxicological Sciences. 108(2). 492–500. 56 indexed citations

Wolf, Kristina, Sheryl G. Wood, Jane A. Hunt, et al.. (2007). Role of CYP3A and CYP2E1 in Alcohol-Mediated Increases in Acetaminophen Hepatotoxicity: Comparison of Wild-Type and Cyp2e1(–/–) Mice. Drug Metabolism and Disposition. 35(7). 1223–1231. 52 indexed citations

Yohe, Herbert C., Kimberley A. O’Hara, Jane A. Hunt, et al.. (2006). Involvement of Toll-like receptor 4 in acetaminophen hepatotoxicity. American Journal of Physiology-Gastrointestinal and Liver Physiology. 290(6). G1269–G1279. 54 indexed citations

Rose, Kelly, Vsevolod E. Kostrubsky, & Jasminder Sahi. (2006). Hepatobiliary Disposition in Primary Cultures of Dog and Monkey Hepatocytes. Molecular Pharmaceutics. 3(3). 266–274. 9 indexed citations

Kostrubsky, Vsevolod E., Sheryl G. Wood, Ralph C. Nichols, et al.. (2005). ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES. Drug Metabolism and Disposition. 33(7). 993–1003. 28 indexed citations

Kostrubsky, Vsevolod E.. (2003). Evaluation of Hepatotoxic Potential of Drugs by Inhibition of Bile-Acid Transport in Cultured Primary Human Hepatocytes and Intact Rats. Toxicological Sciences. 76(1). 220–228. 100 indexed citations

Wen, Yuan H., Jasminder Sahi, Shaila Kulkarni, et al.. (2002). Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes. Drug Metabolism and Disposition. 30(9). 977–984. 38 indexed citations

Kostrubsky, Vsevolod E., et al.. (2001). The effect of troglitazone biliary excretion on metabolite distribution and cholestasis in transporter-deficient rats.. PubMed. 29(12). 1561–6. 38 indexed citations

10.

Runge, Dieter, Christoph Köhler, Vsevolod E. Kostrubsky, et al.. (2000). Induction of Cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but Not of CYP2C9, CYP2C19, Multidrug Resistance (MDR-1) and Multidrug Resistance Associated Protein (MRP-1) by Prototypical Inducers in Human Hepatocytes. Biochemical and Biophysical Research Communications. 273(1). 333–341. 106 indexed citations

11.

Kostrubsky, Vsevolod E., Jacqueline F. Sinclair, Raman Venkataramanan, et al.. (2000). The Role of Conjugation in Hepatotoxicity of Troglitazone in Human and Porcine Hepatocyte Cultures. Drug Metabolism and Disposition. 28(10). 1192–1197. 65 indexed citations

12.

Sinclair, Jacqueline F., Juliana G. Szakacs, Sheryl G. Wood, et al.. (2000). Acetaminophen hepatotoxicity precipitated by short-term treatment of rats with ethanol and isopentanol. Biochemical Pharmacology. 59(4). 445–454. 32 indexed citations

13.

Jacobs, Judith M., Calen Nichols, Angeline S. Andrew, et al.. (1999). Effect of Arsenite on Induction of CYP1A, CYP2B, and CYP3A in Primary Cultures of Rat Hepatocytes. Toxicology and Applied Pharmacology. 157(1). 51–59. 49 indexed citations

14.

Runge, D., Dieter Runge, Kenneth Dorko, et al.. (1999). Epidermal growth factor- and hepatocyte growth factor-receptor activity in serum-free cultures of human hepatocytes. Journal of Hepatology. 30(2). 265–274. 42 indexed citations

15.

Michalopoulos, George K., William C. Bowen, Donna Beer–Stolz, et al.. (1999). Morphogenetic Events in Mixed Cultures of Rat Hepatocytes and Nonparenchymal Cells Maintained in Biological Matrices in the Presence of Hepatocyte Growth Factor and Epidermal Growth Factor. Hepatology. 29(1). 90–100. 98 indexed citations

16.

Kostrubsky, Vsevolod E., Raman Venkataramanan, Kenneth Dorko, et al.. (1999). The Use of Human Hepatocyte Cultures to Study the Induction of Cytochrome P-450. Drug Metabolism and Disposition. 27(8). 887–894. 117 indexed citations

17.

Kostrubsky, Vsevolod E., Lionel D. Lewis, Stephen C. Strom, et al.. (1998). Induction of Cytochrome P4503A by Taxol in Primary Cultures of Human Hepatocytes. Archives of Biochemistry and Biophysics. 355(2). 131–136. 67 indexed citations

18.

Kostrubsky, Vsevolod E., Juliana G. Szakacs, Elizabeth H. Jeffery, et al.. (1997). Role of CYP3A in Ethanol-Mediated Increases in Acetaminophen Hepatotoxicity. Toxicology and Applied Pharmacology. 143(2). 315–323. 53 indexed citations

19.

Kostrubsky, Vsevolod E., Lionel D. Lewis, Sheryl G. Wood, et al.. (1997). Effect of Taxol on Cytochrome P450 3A and Acetaminophen Toxicity in Cultured Rat Hepatocytes: Comparison to Dexamethasone. Toxicology and Applied Pharmacology. 142(1). 79–86. 33 indexed citations

20.

Kostrubsky, Vsevolod E., Sheryl G. Wood, Juliana G. Szakacs, et al.. (1995). Acute hepatotoxicity of acetaminophen in rats treated with ethanol plus isopentanol. Biochemical Pharmacology. 50(11). 1743–1748. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact